See every side of every news story
Published loading...Updated

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric ...

Summary by Hastings Tribune
NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Wednesday, July 9, 2025.
Sources are mostly out of (0)